Association of IFITM3 with the efficacy of anti-PD1/PD-L1 therapy and regulation of immunosensitivity via MHC-I regulation in SCLC.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.8105
Abstract: 8105 Background: Majority of small cell lung cancer (SCLC) patients exhibit resistance to immune checkpoint inhibitors (ICIs), which is associated with the downregulation of major histocompatibility complex class I (MHC-I) molecules. This study investigates the… read more here.
Keywords: ifitm3 expression; ifitm3; association ifitm3; regulation ... See more keywords